Effects of veratrine on skeletal muscle mitochondria: Ultrastructural, cytochemical, and morphometrical studies

Microscopy Research and Technique

Volumn 69, Issue 2, 2006, Pages 108-118

  Reitas, Erika Maria Silva ^a   Fagian, Márcia M ^a   Da Cruz Höfling, Maria Alice ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Cytochemistry; Mitochondria; Morphometry; Skeletal muscle; Ultrastructure; Veratrine

Indexed keywords

ALKALOIDS; BIOCHEMISTRY; CELL MEMBRANES; CYTOLOGY; METABOLITES; MICROSTRUCTURE; MUSCLE; PHOSPHOLIPIDS;

CYTOCHEMICAL; CYTOCHEMISTRY; MITOCHONDRIAS; MORPHOMETRY; NA+ CHANNEL; SKELETAL MUSCLE; TARGET VOLTAGE; ULTRASTRUCTURE; VARIABLE CONCENTRATION; VERATRINE;

MITOCHONDRIA;

CEVADINE; CYTOCHROME C OXIDASE; MEMBRANE PHOSPHOLIPID; NEUROTOXIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; SUCCINATE DEHYDROGENASE; VOLTAGE GATED SODIUM CHANNEL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BREATHING RATE; CELL ULTRASTRUCTURE; CONCENTRATION (PARAMETERS); CYTOCHEMISTRY; ELECTRON MICROSCOPY; ENZYME ACTIVITY; MORPHOMETRICS; MOUSE; MUSCLE MITOCHONDRION; MUSCLE NECROSIS; NONHUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; RAT; RESPIRATION CONTROL; RESPIRATORY CHAIN; SKELETAL MUSCLE; TARGET CELL;

ANIMALIA;

EID: 33644647777     PISSN: 1059910X     EISSN: 10970029     Source Type: Journal    
DOI: 10.1002/jemt.20280     Document Type: Article

References (60)

1. 2+ and excitability. Cell Calcium 21:81-91.
2. Benforado JM. 1967. The veratrum alkaloids. In: Root WS, Hofmann FG, editors. Physiological Pharmacology. New York: Academic Press. pp. 331-398.
3. Bernardi P. 1999. Mitochondrial transport of cations: channels, exchangers, and permeability transition. Physiol Rev 79:1127-1155.
4. Candipan RC, Sjöstrand FS. 1984a. Permeability changes in isolated liver mitochondria during different metabolic states. J Ultrastruct Res 89:212-222.
5. Candipan RC, Sjöstrand FS. 1984b. An analysis of the contribution of the preparatory technique to the appearance of condensed and orthodox confirmation liver mitochondria. J Ultrastruct Res 89: 281-294.
6. Catterall WA. 1980. Neurotoxins that act on voltage-sensitive sodium channels in excitable membranes. Annu Rev Pharmacol Toxicol 20: 15-43.
7. Chance B, Williams GR. 1956. The respiration chain and oxidative phosphorylation. Adv Enzymol 17:65-134.
8. i. J Neurosci 20:2094-2103.
9. Cruz-Höfling MA, Rodrigues-Simioni L. 1998. In vitro studies of the ultrastructural changes induced by guanidine in the nerves, muscle fibers and neuromuscular junction of the mouse diaphragm. Gen Pharmacol 30:705-711.
10. Cruz-Höfling MA, Vital Brazil O. 1990. Alterações ultraestruturais causadas pela veratrina no diafragma isolado de camundongo. In: Proceedings of the V Annual Meeting of FESBE, Caxambu, MG, Brazil. p. 324.
11. Cruz-Höfling MA, Dal Pai-Silva M, Freitas EMS. 2002. Mouse extensor digitorum longus and soleus show distinctive ultrastructural changes induced by veratrine. J Submicrosc Cytol Pathol 34:305-313
12. Felix JP, Williams BS, Priest BT, Brochu RM, Dick IE, Warren VA, Yan L, Slaughter RS, Kaczorowski GJ, Smith MM, Garcia ML. 2004. Functional assay of voltage-gated sodium channels using membrane potential-sensitive dyes. Assay Drug Dev Technol 2:260-268.
13. Floridi A, Castiglione S, Bianchi C. 1989. Sites of inhibition of mitochondrial electron transport by rhein. Biochem Pharmacol 38:743-751.
14. Freitas EMS, Dal Pai-Silva M, Cruz-Höfling MA. 2001. Histoenzymological and ultrastructural changes in lateral muscle fibers of Oreochromis niloticus (Teleostei: Cichlidae) after local injection of veratrine. Histochem Cell Biol 116:525-534.
15. Freitas EMS, Dal Pai-Silva M, Cruz-Höfling MA. 2002. Histochemical differences in the responses of predominantly fast-twitch glycolytic muscle and slow-twitch oxidative muscle to veratrine. Toxicon 40: 1471-1481.
16. 2 complex. Toxicon 22:85-98.
17. Gornall AG, Barwill CI, David MM. 1949. Determination of serum proteins by means of biuret reaction. J Biol Chem 177:751-757.
18. Gutierrez JM, Ownby CL, Odell GV. 1984. Pathogenesis of myonecrosis induced by crude venom and a myotoxin of Bothrops asper. Exp Mol Pathol 40:367-379.
19. 2 isolated from the venom of the snake Bothrops jararacussu. Exp Mol Pathol 55: 217-229.
20. Hackenbrock CR. 1966. Ultrastructural bases for metabolically linked mechanical activity in mitochondria, I. Reversible ultrastructural changes with change in metabolic steady state in isolated mitochondria. J Cell Biol 30:269-297.
21. Hanker JS, Kusyk C, Bloom FE, Pearse AGE. 1973. The demonstration of dehydrogenases and monoamine oxidase by the formation of osmium blacks at the sites of Hatchett's Brown. Histochemie 33: 205-230.
22. Harris JB, Johnson MA. 1978. Further observations on the pathological responses of rat skeletal muscle to toxins isolated from the venom of the Australian tiger snake, Notechis scutatus scutatus. Clin Exp Pharmacol Physiol 5:587-600.
23. Harris JB, Johnson MA, Karlsson E. 1975. Pathological responses of rat skeletal muscle to a single subcutaneous injection of a toxin isolated from the venom of the Australian tiger snake, Notechis scutatus scutatus. Clin Exp Pharmacol Physiol 2:383-404.
24. Honerjäger P, Dugas M, Zong X-G. 1992. Mutually exclusive action of cationic veratridine and cevadine at an intracellular site of the cardiac sodium channel. J Gen Physiol 99:699-720.
25. Iosi F, Santini MT, Malorni W. 1993. Membrane and cytoskeleton are intracellular targets of rhein in A431 cells. Anticancer Res 13:545-554.
26. Jordan J, Galindo MF, Calvo S, González-Garcia C, Ceña V. 2000. Veratridine induces apoptotic death in bovine chromaffin cells through superoxide production. Br J Pharmacol 130:1496-1504.
27. Jórdan J, Galindo MF, Tornero D, Benavides A, Gonzalez C, Agapito MT, Gonzalez-Garcia C, Cena V. 2002. Superoxide anions mediate veratridine-induced cytochrome c release and caspase activity in bovine chromaffin cells. Br J Pharmacol 137:993-1000.
28. Jórdan J, Galindo MF, González-Garcia C, Ceña V. 2003. Role and regulation of p53 in depolarization-induced neuronal death. Neuroscience 122:707-715.
29. Kar S, Issa AM, Seto D, Auld DS, Collier B, Quirion R. 1998. Amyloid β-peptide inhibits high-affinity choline uptake and acetylcholine release in rat hippocampal slices. J Neurochem 70:2179-2187.
30. Kean EA. 1968. Rhein: an inhibitor of mitochondrial oxidations. Arch Biochim Biophys 127:528-533.
31. Kerpel-Fronius S, Hajós F. 1968. The use of ferricyanide for the light and electron microscopic demonstration of succinic dehydrogenase activity. Histochemie 14:343-351.
32. + channels induces necrosis and apoptosis of rat superior cervical ganglion cells in vitro. Brain Res Bull 51:345-355.
33. Laiho KU, Trump BF. 1975. Studies on the pathogenesis of cell injury: effects of inhibitors of metabolism and membrane function on the mitochondria of Ehrlich ascites tumor cells. Lab Invest 32:163-182.
34. Lin S, Fujii M, Hou DX. 2003. Rhein induces apoptosis in HL-60 cells via reactive oxygen species-independent mitochondrial death pathway. Arch Biochem Biophys 418:99-107.
35. Lindal S, Lund I, Torbergsen T, Aasly J, Mellgren SI, Borud O, Monstad P. 1992. Mitochondrial diseases and myopathies: a series of muscle biopsy specimens with ultrastructural changes in the mitochondria. Ultrastruct Pathol 16:263-275.
36. Lizasoain I, Knowles RG, Moncada S. 1995. Inhibition by lamotrigine of the generation of nitric oxide in rat forebrain slices. J Neurochem 64:636-642.
37. Loschmann PA, Eblen F, Wullner U, Wachtel H, Kockgether T. 1995. Lamotrigine has no antiparkinsonian activity in rat models of Parkinson's disease. Eur J Pharmacol 284:129-134.
38. Mattiello-Sverzuta AC, Cruz-Höfling MA. 2000. Toxin 2 (PhTx2), a neurotoxic fraction from Phoneutria nigriventer spider venom, causes acute morphological changes in mouse skeletal muscle. Toxicon 38:793-812.
39. Melmed C, Karpati G, Carpenter S. 1975. Experimental mitochondrial myopathy produced by in vitro uncoupling of oxidative phosphorylation. J Neurol Sci 26:305-318.
40. Melo PA, Ownby CL. 1996. Different sensitivity of fast- and slow-twitch muscles to some snake venoms and myotoxins. Toxicon 34:653-669.
41. Moreno-Sánchez R, Hansford RG. 1988. Relation between cytosolic free calcium and respiratory rates in cardiac myocytes. Am J Physiol 255:H347-H357.
42. Nánási PP, Varró A, Lathrop DA, Bryant SH. 1994. Effects of veratridine on Na and Ca currents in frog skeletal muscle. Gen Pharmacol 25:1661-1666.
43. Nishino I, Kobayashi O, Goto Y-I, Kurihara M, Kumagai K, Fujita T, Hashimoto K, Horai S, Nonaka I. 1998. A new congenital muscular dystrophy with mitochondrial structural abnormalities. Muscle Nerve 21:40-47.
44. Peixoto F, Carvalho MJ, Almeida J, Matos PA. 2004. Daphnetoxin interacts with mitochondrial oxidative phosphorylation and induces membrane permeability transition in rat liver. Planta Med 70: 1064-1068.
45. Popinigis J, Wrzolkowa T, Swierczynski J. 1971. Changes in mitochondrial ultrastructure induced by gramicidin plus protamine. Biochem Biophys Acta 245:70-79.
46. Popinigis J, Wozniak M, Roszkiewicz A. 1979. Butylmalonate counteracts the inhibitory effect of protamine on succinate oxidation. An ultrastructural interpretation. Biochim Biophys Res Comm 86:801-807.
47. Rohlf FJ, Marcus LF. 1993. A revolution in morphometrics. Tree 8:129-132.
48. Sahgal V, Subramani V, Hughes R, Shah A, Singh H. 1979. On the pathogenesis of mitochondrial myopathies. An experimental study. Acta Neuropathol (Berl) 46:177-183.
49. Santoro B, Bigini P, Levandis G, Nobile V, Biggiogera M, Botti F, Mennini T, Curti D. 2004. Evidence for chronic mitochondrial impairment in the cervical spinal cord of a murine model of motor neuron disease. Neurobiol Dis 17:349-357.
50. Savolainen KM, Loikkanen J, Eerikainen S, Naarala J. 1998. Interactions of excitatory neurotransmitters and xenobiotics in excitatory and oxidative stress: glutamate and lead. Toxicol Lett 102-103: 363-367.
51. Seligman AM, Karnovsky MJ, Wasserkrug HL, Hanker JS. 1968. Nondroplet ultrastructural demonstration of cytochrome oxidase activity with a polymerizing osmiophilic reagent, diaminobenzidine (DAB). J Cell Biol 38:1-14.
52. Shah AJ, Sahgal V, Muschler G, Subramani V, Singh H. 1982. Morphogenesis of the mitochondrial alterations in muscle diseases. J Neurol Sci 55:25-37.
53. Shimojo M, Takasugi K, Yamamoto I, Funato H, Mochizuki H, Kohsaka S. 1999. Neuroprotective action of a novel compound-M50463-in primary cultured neurons. Brain Res 815:131-139.
54. Sokolove PM, Westphal PA, Kester MB, Wierwille R, Sikora-Van-Meter K. 1989. Duramycin effects on the structure and function of heart mitochondria. I. Structural alterations and changes in membrane permeability. Biochim Biophys Acta 983:15-22.
55. Son SL, Wong K, Strichartz G. 2004. Antagonism by local anesthetics of sodium channel activators in the presence of scorpion toxins: two mechanisms for competitive inhibition. Cell Mol Neurobiol 24:565-577.
56. Tonkonogi M, Sahlin K. 1997. Rate of oxidative phosphorylation in isolated mitochondria from human skeletal muscle: effect of training status. Acta Physiol Scand 161:345-353.
57. Ulbricht W. 1998. Effects of veratridine on sodium currents and fluxes. Rev Physiol Biochem Pharmacol 133:1-54.
58. Vital Brazil O, Fontana MD. 1985. Unequal depolarization of the membrane of the rat diaphragm muscle fibers caused by veratrine. Pflügers Arch 404:45-49.
59. Wang S-Y, Wang GK. 2003. Voltage-gated sodium channels as primary targets of diverse lipid-soluble neurotoxins. Cell Signal 15:151-159.
60. + channels. J Neurosci Methods 137:79-85.